AKT has pleiotropic oncogenic functions that include inhibition of multiple tumor suppressors, such as FOXO1/FOXO3A, Bad, p27, and GSK3β, and promotion of other oncogenic pathways, such as mTOR, p70S6K1, Rac, and survivin [16, 46]. This evidence concerns the gene BIRC5 and neoplasm.